Reuters logo
BRIEF-FDA Staff says "among those abusing Opana ER, reformulation caused marked shift in route by which drug is abused, from nasal to injection"
March 9, 2017 / 2:22 PM / 7 months ago

BRIEF-FDA Staff says "among those abusing Opana ER, reformulation caused marked shift in route by which drug is abused, from nasal to injection"

March 9 (Reuters) - Endo International Plc

* FDA staff : “among those abusing opana er, reformulation caused marked shift in the route by which drug is abused, from nasal to injection” Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below